R W Shafer|T C Merigan - JoVE Visualize

Showing results (221-230 of 289) with videos related to

Pageof 29

Sort By:

The New England Journal of Medicine|September 2, 1976

Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitisH B Greenberg, R B Pollard, L I Lutwick, et al.

JAMA|April 23, 1982

Vidarabine monophosphate and human leukocyte interferon in chronic hepatitis B infectionC I Smith, L W Kitchen, G H Scullard, et al.

AIDS Research and Human Retroviruses|July 13, 2000

HIV type 1 envelope subtype C sequences from recent seroconverters in ZimbabweM Batra, P C Tien, R W Shafer, et al.

Nucleic Acids Research|December 11, 1999

Human immunodeficiency virus reverse transcriptase and protease sequence databaseR W Shafer, D R Jung, B J Betts, et al.

Journal of Virology|October 24, 2000

Genotypic, phenotypic, and modeling studies of a deletion in the beta3-beta4 region of the human immunodeficiency virus type 1 reverse transcriptase gene that is associated with resistance to nucleoside reverse transcriptase inhibitorsM A Winters, K L Coolley, P Cheng, et al.

Antimicrobial Agents and Chemotherapy|August 1, 1989

Pharmacokinetics of rifabutinM H Skinner, M Hsieh, J Torseth, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1985

Treatment of nasopharyngeal carcinoma with human leukocyte interferonJ M Connors, W A Andiman, C B Howarth, et al.

Annals of Neurology|July 1, 1984

Human leukocyte interferon administration to patients with symptomatic and suspected rabiesT C Merigan, G M Baer, W G Winkler, et al.

Journal of Acquired Immune Deficiency Syndromes|January 1, 1992

Plasma viremia in human immunodeficiency virus infection: relationship to stage of disease and antiviral treatmentD A Katzenstein, M Holodniy, D M Israelski, et al.

The Journal of Infectious Diseases|May 6, 1999

Clinical resistance patterns and responses to two sequential protease inhibitor regimens in saquinavir and reverse transcriptase inhibitor-experienced personsJ Lawrence, J Schapiro, M Winters, et al.

Pageof 29

Showing results (221-230 of 289) with videos related to

Sort By:

Pageof 29

The New England Journal of Medicine|September 2, 1976

Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitisH B Greenberg, R B Pollard, L I Lutwick, et al.

JAMA|April 23, 1982

Vidarabine monophosphate and human leukocyte interferon in chronic hepatitis B infectionC I Smith, L W Kitchen, G H Scullard, et al.

AIDS Research and Human Retroviruses|July 13, 2000

HIV type 1 envelope subtype C sequences from recent seroconverters in ZimbabweM Batra, P C Tien, R W Shafer, et al.

Nucleic Acids Research|December 11, 1999

Human immunodeficiency virus reverse transcriptase and protease sequence databaseR W Shafer, D R Jung, B J Betts, et al.

Journal of Virology|October 24, 2000

Genotypic, phenotypic, and modeling studies of a deletion in the beta3-beta4 region of the human immunodeficiency virus type 1 reverse transcriptase gene that is associated with resistance to nucleoside reverse transcriptase inhibitorsM A Winters, K L Coolley, P Cheng, et al.

Antimicrobial Agents and Chemotherapy|August 1, 1989

Pharmacokinetics of rifabutinM H Skinner, M Hsieh, J Torseth, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1985

Treatment of nasopharyngeal carcinoma with human leukocyte interferonJ M Connors, W A Andiman, C B Howarth, et al.

Annals of Neurology|July 1, 1984

Human leukocyte interferon administration to patients with symptomatic and suspected rabiesT C Merigan, G M Baer, W G Winkler, et al.

Journal of Acquired Immune Deficiency Syndromes|January 1, 1992

Plasma viremia in human immunodeficiency virus infection: relationship to stage of disease and antiviral treatmentD A Katzenstein, M Holodniy, D M Israelski, et al.

The Journal of Infectious Diseases|May 6, 1999

Clinical resistance patterns and responses to two sequential protease inhibitor regimens in saquinavir and reverse transcriptase inhibitor-experienced personsJ Lawrence, J Schapiro, M Winters, et al.

Pageof 29